Drug development and analysis review

SKM Haque, ES Ratemi - Pharmaceutical Chemistry Journal, 2017 - Springer
The drug discovery has now evolved into a much more scientific and rational process due to
better understanding of biological processes and the underlying chemistry, owing to the …

Synthesis and characterization of a molecularly imprinted polymer (MIP) for solid-phase extraction of the antidiabetic gliclazide from human plasma

I Vasconcelos, PHR da Silva, DRD Dias… - Materials Science and …, 2020 - Elsevier
Gliclazide is a sulfonylurea frequently prescribed for the management of type 2 diabetes
mellitus in elderly patients and for patients with chronic renal or hepatic diseases. Even …

Chemical constituents of Leucas zeylanica and their chemotaxonomic significance

N Nidhal, XM Zhou, G Chen, B Zhang, C Han… - … systematics and ecology, 2020 - Elsevier
Chemical study of the whole plant of Leucas zeylanica (L.) B. Br. has led to isolation of a
new norditerpenoid isomer (1), along with 29 known compounds, including one …

Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity

M Ibrahim, S Munir, S Ahmed… - Oxidative Medicine …, 2022 - Wiley Online Library
The poor solubility of the antidiabetic drug gliclazide (Glc) is due to its hydrophobic nature.
This research is aimed at improving Glc's solubility and drug release profile, as well as at …

A simple and sensitive HPLC-MS/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study

S Wang, XJ Ni, YG Wen, HS Xie, JR Chen… - … of Pharmaceutical and …, 2021 - Elsevier
Montelukast is a potent and selective antagonist of the cysteinyl leukotriene receptor 1
subtype (CysLT1) and widely used in the form of oral tablets and granules for asthma …

LC-MS/MS analytical method for determination of montelukast in human plasma and its application to a bioequivalence study

R Said - Current Pharmaceutical Analysis, 2023 - ingentaconnect.com
Background: This study aimed to develop a sensitive, rapid method based on HPLC-MS/MS
for the quantification of Montelukast in human plasma utilizing Montelukast-D6 as an internal …

Development and validation of novel HPTLC method for the simultaneous estimation of amlodipine besylate and telmisartan in tablet dosage form using ICH Q2 (R1) …

TB Deshmukh, SS Deo, FS Inam… - Journal of the Chinese …, 2018 - Taylor & Francis
A new simple, specific, accurate, precise and robust normal phase high performance thin
layer chromatography (HPTLC) method were developed and validated for simultaneous …

Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method

AN Zaid, MN Abualhasan, DG Watson… - Drug design …, 2015 - Taylor & Francis
Background Montelukast (MT) is a leukotriene D4 antagonist. It is an effective and safe
medicine for the prophylaxis and treatment of chronic asthma. It is also used to prevent acute …

Transfer of montelukast into human milk during lactation

P Datta, K Rewers-Felkins, T Baker… - Breastfeeding …, 2017 - liebertpub.com
Aim: The aim of this study was to determine levels of montelukast in human milk and to
develop a simple, sensitive analytical method using mass spectrometry. Methods: Milk …

Development and validation of an LC–MS/MS method for the simultaneous quantification of seven constituents in rat plasma and application in a pharmacokinetic …

A Zhao, L Zhang, R Li, J Shang, H Yi… - Biomedical …, 2018 - Wiley Online Library
A sensitive, specific and accurate liquid chromatography–tandem mass spectrometry (LC–
MS/MS) method was developed and validated for the simultaneous determination of seven …